Tirzepatide (Tirz) is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist developed for cutting-edge research into metabolic disorders, glucose regulation, and weight management. Its unique dual-incretin mechanism improves insulin secretion, enhances insulin sensitivity, and suppresses appetite, making it a powerful candidate for preclinical obesity and diabetes studies.

Research Applications & Potential Effects:

• Studies on blood glucose control and insulin resistance

• Research into weight loss and caloric intake reduction

• Evaluation of dual incretin synergy in metabolic health

• Preclinical investigations of cardiovascular and lipid profile changes

Supplied as a sterile, Lyophilised powder in liquid to ensure maximum stability and purity for precise laboratory experiments.

Molecular Formula: C225H348N48O68
Molar Mass: 4813.52 g/mol
Form: Lyophilised powder in liquid
Purity: ≥ 99% (HPLC)
Storage: Store at −20 °C, protect from light
Intended Use: Strictly for research purposes only. Not for human consumption, medical, or veterinary use.
CAS Number: 2023788-19-2